Tirzepatide is a first-in-class, long-acting dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is a 39-amino acid modified peptide with a C20 fatty diacid moiety that enables albumin binding and prolongs its half-life, allowing for once-weekly dosing. tirzepatide is approved for use as an adjunct to a calorie-reduced diet and increased physical activity
Tirzepatide is a first-in-class, long-acting dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is a 39-amino acid modified peptide with a C20 fatty diacid moiety that enables albumin binding and prolongs its half-life, allowing for once-weekly dosing. tirzepatide is approved for use as an adjunct to a calorie-reduced diet and increased physical activity
| MG | T55, TR10, TR15, TR20, TR30, TR40, TR50, TR50, TR60, TR100, TR120 |
|---|
Reviews
There are no reviews yet.